検索
Amgen Inc
AMGNウォッチリストに追加
376.860USD
+5.360+1.44%
取引時間 （ET）15分遅れの株価
203.05B時価総額
26.02直近12ヶ月PER
詳細情報 Amgen Inc 企業名
Amgen Inc. is a biotechnology company. It discovers, develops, manufactures and delivers medicines for the toughest diseases. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve people’s lives. It operates in the human therapeutics segment. Its marketed products portfolio includes EPOGEN (epoetin alfa); Aranesp (darbepoetin alfa); Parsabiv (etelcalcetide); Neulasta (pegfilgrastim); KANJINTI (trastuzumab-anns); Otezla; BLINCYTO (blinatumomab); ACTIMMUNE (interferon gamma-1b); Neulasta (pegfilgrastim); Sensipar/Mimpara (cinacalcet); Prolia (denosumab); ENBREL; QUINSAIR (levofloxacin); Repatha (evolocumab) and others. It markets ENBREL, a tumor necrosis factor blocker, in the United States and Canada. It markets Otezla, a small molecule that inhibits phosphodiesterase 4, in many countries around the world. It markets Repatha, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in many countries around the world.
Amgen Incの企業情報
企業コードAMGN
会社名Amgen Inc
上場日Jun 17, 1983
最高経営責任者「CEO」Bradway (Robert A)
従業員数28000
証券種類Ordinary Share
決算期末Jun 17
本社所在地One Amgen Center Drive
都市THOUSAND OAKS
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号91320-1799
電話番号18054471000
ウェブサイトhttps://www.amgen.com/
企業コードAMGN
上場日Jun 17, 1983
最高経営責任者「CEO」Bradway (Robert A)
Amgen Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Robert A. (Bob) Bradway
Mr. Robert A. (Bob) Bradway
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
645.95K
+0.51%
Mr. Esteban Santos
Mr. Esteban Santos
Executive Vice President - Operations
Executive Vice President - Operations
75.13K
+0.59%
Mr. Murdo Gordon
Mr. Murdo Gordon
Executive Vice President - Global Commercial Operations
Executive Vice President - Global Commercial Operations
48.67K
+1.91%
Mr. Derek Miller
Mr. Derek Miller
Senior Vice President - Human Resources
Senior Vice President - Human Resources
12.07K
+2.25%
Dr. Wanda M. Austin, Ph.D.
Dr. Wanda M. Austin, Ph.D.
Independent Director
Independent Director
8.02K
+8.29%
Ms. Rachna Khosla
Ms. Rachna Khosla
Senior Vice President - Business Development
Senior Vice President - Business Development
7.93K
+1.30%
Ms. Nancy A. Grygiel
Ms. Nancy A. Grygiel
Senior Vice President, Chief Compliance Officer
Senior Vice President, Chief Compliance Officer
6.10K
-18.98%
Dr. Tyler Jacks
Dr. Tyler Jacks
Independent Director
Independent Director
4.11K
+16.18%
Dr. Brian J. Druker, M.D.
Dr. Brian J. Druker, M.D.
Independent Director
Independent Director
3.82K
+17.39%
Ms. Mary E. Klotman
Ms. Mary E. Klotman
Independent Director
Independent Director
1.38K
+48.05%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Robert A. (Bob) Bradway
Mr. Robert A. (Bob) Bradway
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
645.95K
+0.51%
Mr. Esteban Santos
Mr. Esteban Santos
Executive Vice President - Operations
Executive Vice President - Operations
75.13K
+0.59%
Mr. Murdo Gordon
Mr. Murdo Gordon
Executive Vice President - Global Commercial Operations
Executive Vice President - Global Commercial Operations
48.67K
+1.91%
Mr. Derek Miller
Mr. Derek Miller
Senior Vice President - Human Resources
Senior Vice President - Human Resources
12.07K
+2.25%
Dr. Wanda M. Austin, Ph.D.
Dr. Wanda M. Austin, Ph.D.
Independent Director
Independent Director
8.02K
+8.29%
Ms. Rachna Khosla
Ms. Rachna Khosla
Senior Vice President - Business Development
Senior Vice President - Business Development
7.93K
+1.30%
よくある質問
Amgen Incの上位5名の株主は誰ですか？
Amgen Incの上位5名の株主は以下のとおりです。Mr. Robert A. (Bob) Bradway
Amgen Inc（AMGN）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Amgen Incの株式を保有している機関は4665社あり、保有株式の総市場価値は約460.83Mで、全体の85.38%を占めています。2025Q4と比較して、機関の持ち株は2252779.00増加しています。
Amgen Incの最大の収益源は何ですか？
2026Q1において、Other products部門がAmgen Incにとって最大の収益を生み出しており、その金額は7.26Bで、全収益の19.76%を占めています。